Europeiska unionen - svenska - EMA (European Medicines Agency)

sanofi b.v. - tyrotropin alfa - sköldkörtelnoplasmer - främre hypofys lob hormoner och analoger, hypofysen och hypotalamus hormoner och derivat - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

aspen pharma trading limited - levotyroxinnatrium (hydrat) - tablett - 100 mikrogram - levotyroxinnatrium (hydrat) 111,3 mikrog aktiv substans - levotyroxinnatrium

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

aspen pharma trading limited - levotyroxinnatrium (hydrat) - tablett - 125 mikrogram - levotyroxinnatrium (hydrat) 139,1 mikrog aktiv substans - levotyroxinnatrium

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

aspen pharma trading limited - levotyroxinnatrium (hydrat) - tablett - 150 mikrogram - levotyroxinnatrium (hydrat) 166,9 mikrog aktiv substans - levotyroxinnatrium

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

aspen pharma trading limited - levotyroxinnatrium (hydrat) - tablett - 175 mikrogram - levotyroxinnatrium (hydrat) 194,7 mikrog aktiv substans - levotyroxinnatrium

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

aspen pharma trading limited - levotyroxinnatrium (hydrat) - tablett - 200 mikrogram - levotyroxinnatrium (hydrat) 222,5 mikrog aktiv substans - levotyroxinnatrium

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

aspen pharma trading limited - levotyroxinnatrium (hydrat) - tablett - 25 mikrogram - levotyroxinnatrium (hydrat) 27,8 mikrog aktiv substans - levotyroxinnatrium

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

aspen pharma trading limited - levotyroxinnatrium (hydrat) - tablett - 50 mikrogram - levotyroxinnatrium (hydrat) 56 mikrog aktiv substans - levotyroxinnatrium

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

aspen pharma trading limited - levotyroxinnatrium (hydrat) - tablett - 75 mikrogram - levotyroxinnatrium (hydrat) 83,4 mikrog aktiv substans - levotyroxinnatrium

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

uni-pharma kleon tsetis pharmaceutical laboratories s.a. - levotyroxinnatrium (hydrat) - tablett - 50 mikrogram - levotyroxinnatrium (hydrat) 56 mikrog aktiv substans